Plenty of reasons why Mesoblast are setting up the additional phase 3 COVID-19 ARDS trial … in addition to the extraordinary high daily death numbers in the USA, new variants are just another reason why SI is all over it - remember monoclonal antibodies have proven to be ineffective against Omicron so who knows whether other approved treatments will save lives against new variants ?
https://www.indiatoday.in/coronavir...ossibly-deadlier-warns-who-1910627-2022-02-09
Next Covid-19 variant will be more infectious than Omicron, possibly deadlier, warns WHO
WHO epidemiologist and technical lead on Covid-19 Dr Maria Van Kerkhove has warned that the next variant will be more transmissible, and perhaps, more deadly than its predecessors.
https://www.vox.com/22923891/omicron-subvariant-ba2-coronavirus
We regret to inform you that we are now discussing subvariants
BA.2 is a fast-spreading variant of the omicron variant. Here’s what we know
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-231
-
- There are more pages in this discussion • 675 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |